673 related articles for article (PubMed ID: 9812244)
21. [Health status indicators: features of the economic approach].
Ghislandi S; Bertolini G; Garattini L
Epidemiol Prev; 2000; 24(6):262-9. PubMed ID: 11219203
[TBL] [Abstract][Full Text] [Related]
22. Patient preference quality of life measures in dermatology.
McCombs K; Chen SC
Dermatol Ther; 2007; 20(2):102-9. PubMed ID: 17537138
[TBL] [Abstract][Full Text] [Related]
23. Why we need a health-related quality of life CPM.
Stec P; Schatell D; Witten B
Nephrol News Issues; 2008 Mar; 22(3):28-30, 35. PubMed ID: 18372678
[No Abstract] [Full Text] [Related]
24. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
Tubach F; Wells GA; Ravaud P; Dougados M
J Rheumatol; 2005 Oct; 32(10):2025-9. PubMed ID: 16206363
[TBL] [Abstract][Full Text] [Related]
25. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K
J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929
[TBL] [Abstract][Full Text] [Related]
26. Practical applications of usability theory to electronic data collection for clinical trials.
Schmier JK; Kane DW; Halpern MT
Contemp Clin Trials; 2005 Jun; 26(3):376-85. PubMed ID: 15911471
[TBL] [Abstract][Full Text] [Related]
27. Caregivers' assessments of preference-based quality of life in Alzheimer's disease.
Karlawish JH; Zbrozek A; Kinosian B; Gregory A; Ferguson A; Low DV; Glick HA
Alzheimers Dement; 2008 May; 4(3):203-11. PubMed ID: 18631969
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of treatment benefits: clinical endpoints relevant to patients.
Prescrire Int; 2008 Dec; 17(98):260. PubMed ID: 19425279
[TBL] [Abstract][Full Text] [Related]
29. Validity of self-assessment outcome questionnaires: patient-physician discrepancy in outcome interpretation.
Ragab AA
Biomed Sci Instrum; 2003; 39():579-84. PubMed ID: 12724955
[TBL] [Abstract][Full Text] [Related]
30. Concordance between supervised and postal administration of the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) and Asthma Control Questionnaire (ACQ) was very high.
Pinnock H; Juniper EF; Sheikh A
J Clin Epidemiol; 2005 Aug; 58(8):809-14. PubMed ID: 16018916
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in adolescents with epilepsy assessed with a measure for adults.
Stevanovic D
Acta Neurol Scand; 2008 Nov; 118(5):343; discussion 343. PubMed ID: 18462477
[No Abstract] [Full Text] [Related]
32. Measures of health-related quality of life and physical function.
Beaton DE; Schemitsch E
Clin Orthop Relat Res; 2003 Aug; (413):90-105. PubMed ID: 12897600
[TBL] [Abstract][Full Text] [Related]
33. Patient-reported outcome II: selecting appropriate measures for musculoskeletal care.
Haywood KL
Musculoskeletal Care; 2007 Jun; 5(2):72-90. PubMed ID: 17542045
[TBL] [Abstract][Full Text] [Related]
34. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
Richardson G; Manca A
Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
[TBL] [Abstract][Full Text] [Related]
35. [Quality of life assessment and children].
Thastum M
Ugeskr Laeger; 2008 Mar; 170(10):834-8. PubMed ID: 18364167
[TBL] [Abstract][Full Text] [Related]
36. Patient perspective in outcome assessments--perceptions or something more?
Kvien TK; Heiberg T
J Rheumatol; 2003 Apr; 30(4):873-6. PubMed ID: 12672219
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life measurement in symptom management trials.
Ganz PA; Goodwin PJ
J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
[TBL] [Abstract][Full Text] [Related]
38. Differences in what quality-of-life instruments measure.
Ferrans CE
J Natl Cancer Inst Monogr; 2007; (37):22-6. PubMed ID: 17951227
[TBL] [Abstract][Full Text] [Related]
39. Commentary: multilevel endpoints and the problems of theoretical aggregation and overlapping.
Adamiak GT
J Clin Epidemiol; 2008 Feb; 61(2):198-9; author reply 199-201. PubMed ID: 18177794
[No Abstract] [Full Text] [Related]
40. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval.
Burke LB; Kennedy DL; Miskala PH; Papadopoulos EJ; Trentacosti AM
Clin Pharmacol Ther; 2008 Aug; 84(2):281-3. PubMed ID: 18580868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
